Use of antagonist [cetrorelix] versus agonist [triptorelin] GnRH [gonadotropin-releasing hormone] in oocyte recipient endometrium preparation
Phase of Trial: Phase IV
Latest Information Update: 14 Feb 2013
At a glance
- Drugs Cetrorelix (Primary) ; Triptorelin (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 10 Oct 2009 Primary endpoint of clinical pregnancy rate has been met.
- 10 Oct 2009 Results have been presented at the 65th Annual Meeting of the American Society for Reproductive Medicine.
- 07 Oct 2009 Actual end date (1 Oct 2009) added as reported by ClinicalTrials.gov